Key Investment Drivers

Scientific Depth

Scientific Depth

Founding team's academic background (journal IF / citations / academic standing), the irreplaceability of the technology (patent analysis + peer-reviewed publications), and end-to-end technical due diligence by Kyoto Institute scientists.

• ·Early stage — at least one peer-reviewed scientific publication
• ·Series A — at least human clinical data
• ·Series B — at least third-party clinical validation

Strategic Synergy

Strategic Synergy

Synergy with the Group's three business lines (Maison Bijin / Bijin Privé / Toyo Wellness), whether the technology can be absorbed and transformed by the product lines, the complementary relationship with the 80+ patents of the Kyoto Institute, and alignment with the sustainability commitment.

• ·Can be applied across the Group's product lines
• ·Forms complementarity with the 80+ patents
• ·Aligns with the sustainability commitment

Founder Patience

Founder Patience

Through 3-5 in-depth conversations (not slide-deck reviews), we look at whether the founder genuinely believes in long-termism, can sustain a 7-10-year R&D cycle, and shares the values behind the Group's long-term commitment.

• ·3-5 deep interviews
• ·Patience for 7-10 years of R&D
• ·Shares the values the Group has upheld over generations